Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Completed
University of Pennsylvania
Phase 2
2004-12-01
Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these
children may require surgery. In this study, researchers affiliated with the University of
Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of
hyperinsulinism that may be cured by surgery. Eligible participants in this study will have
positron emission tomography (PET) scans with F-DOPA prior to surgery.
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
Completed
Children's Hospital of Philadelphia
Phase 2
2004-12-01
Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these
children may require surgery. In this study, researchers affiliated with the University of
Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of
hyperinsulinism that may be cured by surgery. Eligible participants in this study will have
positron emission tomography (PET) scans with F-DOPA prior to surgery.
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Active, not recruiting
National Cancer Institute (NCI)
Early Phase 1
2010-07-26
RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled PET scan, may
help in guiding surgery and radiation therapy and allow doctors to plan better treatment.
PURPOSE: This clinical trial studies fluorine F 18 fluorodopa-labeled PET scan in planning
surgery and radiation therapy in treating patients with newly diagnosed high- or low-grade
malignant glioma
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
